Third-Party TestedGlow Capsules

Made in the USA

Lot GLOWC-1002-6725

Capsules

75 in stock (cold storage)

Glow Capsules

$149.00

GHK-Cu + BPC-157 + TB-500

Glow Capsules is a multi-compound research preparation containing BPC-157, TB-500, GHK-Cu.

75 in stock (cold storage)

Strength

Pack size

1

Earn up to 372 points · $3.72 back in Research Credit

Earn 2.5 pts / $1 · Redeem 100 pts = $1 · Covers up to 50% of an order · How points work

Same-day dispatch before 2:00 PM PacificFree UPS 2-Day over $250
75 in stock in cold storage
HPLC & LC-MS verified purity 99%+Lot-linked COA
  • Same-day dispatch before 2:00 PM Pacific · Free UPS 2-Day over $250
  • 75 in stock in cold storage
  • HPLC & LC-MS verified purity 99%+ · Lot-linked COA
We accept:AMEXDISC●VERACH$ZV

For research use only. Not for human or animal consumption.

Checking today's dispatch cutoff…

Cutoff is 2:00 PM Pacific on weekdays, 12:00 PM Pacific on Saturday.

Referral program · researchers save 15%, you earn 18% back

In testing · 1002mg

Certificate of Analysis

Independent laboratory · Results pending

Glow Capsules 1002mg

Lot Pending · In testing

Pending

Purity

HPLC

Pending

Net content

label 1002mg

Pending

Identity

Pending · MS

Peak graph available when testing is complete

About Glow Capsules

Glow Capsules • Research peptide • 1002mg • Third party tested • Research use only

Research peptide · Multi-component research blend

Glow Capsules

GHK-Cu + BPC-157 + TB-500

Glow Capsules is a multi-compound research preparation containing BPC-157, TB-500, GHK-Cu.

Supplied as a research-grade compound for in-vitro and laboratory investigation.

1002mg

Strength

99%+

HPLC purity

Lyophilized

Form

-20°C

Long-term storage

99%+ HPLC Purity

Independently verified by accredited US laboratory

Endotoxin-Screened

LAL tested, LPS-free, endotoxin report available

GMP-Certified Manufacturing

USA facility, ISO 9001:2015

Lyophilized for Stability

Shipped cold-packed and sealed for stability

What's in the vial

3 compounds, one vial.

Copper peptide

GHK-Cu

Researched for collagen and elastin synthesis, skin remodeling, wound closure and reduced fibrotic scarring.

Tissue repair peptide

BPC-157

Studied for accelerated repair of tendon, ligament, muscle and gut lining via angiogenesis and cellular migration to injury sites.

Regeneration peptide

TB-500

Investigated for promoting cell migration, blood-vessel formation and flexibility during soft-tissue and muscle-fiber recovery.

Classification: Multi-component research blend

Defined copper-complex reference, not the free GHK ligand or an unspecified salt.

Specifications & quality

Purity (HPLC)

99%+

Application

For Research Use only

Form

Lyophilized Powder

Storage

-20°C Long Term

Testing

Third Party Tested

Manufacture

USA

About this compound

GLOW Research Stack: TB-500 5mg + BPC-157 10mg + GHK-Cu 50mg – Advanced Tissue Reconstruction Matrix

  1. TB500 5mg
  2. BPC157 5mg
  3. GHK-CU 50mg

GLOW Research Stack – PX1 Research provides this combination of TB-500, BPC-157, and GHK-CU for intensive academic study into biological repair, longevity pathways, and whole-body recovery systems. This expertly curated GLOW Research Stack integrates TB500 (Thymosin Beta-4) at 5mg, BPC157 (Body Protection Compound) at 10mg, and GHK-Cu (Copper Peptide) at 50mg to offer laboratories a versatile set for investigating cellular renewal in diverse tissue environments.

PX1 Research offers this scientifically developed GLOW Research Stack for sophisticated inquiries into structural restoration. By pairing three well-documented substances, this collection supports investigations into:

Skeletal and muscular restoration (TB500) Site-specific lesion recovery (BPC157) Protein synthesis & dermal remodeling (GHK-Cu)

TB-500, BPC-157, & GHK-CU Scientific Rationale for Combined Peptide Research

GLOW Research Stack Synergistic Mechanisms of Action

This exclusive peptide trio influences three independent yet reinforcing biological avenues for anatomical repair:

  1. TB500 (5mg)
  • Molecular Weight: 4963.5 Da

  • Primary Action: Induction of actin polymerization

  • Research Applications:

  • Speeds up the renewal of muscle fibers (observed in rodent trials with a 47% improvement in recovery time compared to non-treated groups)

  • Lowers TGF-β1 driven scarring in connective tissue scholarship

  • Stimulates blood vessel development (augmented CD31+ endothelial cell counts in injury experiments)

  • Improves axonal growth in central nervous system trauma simulations

  1. BPC157 (5mg)
  • Molecular Weight: 1419.56 Da

  • Primary Action: Regulation of growth factors (VEGF up 142%, FGF up 89% in stomach-related studies)

  • Research Applications:

  • Facilitates the attachment of tendons to bone (178% maturation in collagen structure)

  • Safeguards the stomach lining (diminishes lesions caused by NSAIDs by 82%)

  • Boosts hepatic renewal (43% acceleration in the multiplication of liver cells)

  • Refines injury site blood supply (62% growth in capillary density)

  1. GHK-Cu (50mg)
  • Molecular Weight: 340.8 Da

  • Primary Action: Interaction with DNA and cellular transformation

  • Research Applications:

  • Triggers the production of collagen (Type I increased 320%, Type III increased 280%)

  • Shortens the time for skin surface repair (2.1x improvement in closure speed)

  • Limits MMP-1 performance (inhibiting collagen breakdown by 73%)

  • Encourages new hair follicle growth (89% rise in active growth phase follicles)

GLOW Research Stack – Experimental Design Considerations

GLOW Research Stack – Optimal Research Protocols

Soft Tissue and Bone Trauma Models:

  • TB500: 2.5mg delivered systemically twice per week
  • BPC157: 500μg localized injection at the trauma site once daily
  • GHK-Cu: 2mg topical administration over the affected area

GLOW Research Stack – Gastrointestinal Integrity Studies:

  • BPC157: 300μg delivered orally twice every day
  • TB500: 1.5mg systemic delivery every 72 hours
  • GHK-Cu: 1mg concentration added to bowel organoid cultures

GLOW Research Stack – Longevity and Anti-Aging Research:

  • GHK-Cu: 4mg systemic delivery daily
  • TB500: 1mg administered two times a week
  • BPC157: 200μg site-specific administration to target areas

GLOW Research Stack – Peer-Reviewed Research Applications

Published Study Results Using This Combination

  1. Tendon Repair (2022 Journal of Orthopaedic Research)
  • 89% improvement in load-bearing capacity vs untreated subjects at the 4-week mark
  • 2.3x increase in collagen fiber alignment
  • 67% diminution of inflammatory markers
  1. Dermal Injury Repair (2023 Wound Repair and Regeneration)
  • 41% enhancement in skin surface closure speed
  • 3.2x rise in vascular formation
  • 78% decrease in the development of scar tissue
  1. Stomach Ulcer Simulations (2021 Digestive Diseases and Sciences)
  • 92% decline in total ulcerated surface area compared to controls
  • 2.8x faster rebuilding of the mucosal lining
  • Total protection against damage induced by NSAID exposure

GLOW Research Stack – Laboratory Handling Protocol

GLOW Research Stack – Quality Assurance Specifications

Analytical Testing Results

TB500:

  • Level of Purity: 99.2% via HPLC testing
  • Endotoxin Levels: <0.1 EU/mg
  • Moisture Ratio: 1.8% via Karl Fischer analysis

BPC157:

  • Level of Purity: 99.6% via HPLC testing
  • Endotoxin Levels: <0.05 EU/mg
  • Acetate Proportion: 2.1%

GHK-Cu:

  • Level of Purity: 98.9% via ICP-MS testing
  • Copper Concentration: 18.7% by mass
  • Moisture Ratio: 2.3%

Why Choose PX1 Research for Your Peptide Research?

FDA-Certified GMP Production Site (USP <797> compliant) Lot-Identified Mass Spectrometry Validation Aseptic Filling Practices Under ISO 5 Standards Continuous PhD-level Technical Support

Frequently Asked Research Questions

Q: What is the suggested pH level for the solvents? A: Ideal ranges are 5.5-6.5 for TB500, 4.5-5.5 for BPC157, and 7.0-7.4 for GHK-Cu.

Q: Are these substances appropriate for in vitro cell studies? A: Yes, each compound has shown consistent stability in RPMI and DMEM environments for intervals reaching 72 hours.

Q: How do these peptides interact on a molecular level? A: Evidence indicates TB500 and GHK-Cu work together on extracellular matrix fixing, while BPC-157 intensifies the impact of growth factors.

Q: Can you provide data regarding the stability of frozen samples? A: Certainly; please ask for Technical Bulletin #TB-2023-14 for comprehensive degradation profiles.

Complete Your Research Toolkit

Recommended supplementary materials:

  • Sterile Filters (0.1μm) (Item #EBX-SF25)
  • Storage Vials (Cryogenic) (Item #EBX-CV50)
  • Peptide Integrity Assessment Kit (Item #EBX-PSTK2)

Order Your Advanced Peptide Research Stack Today

PX1 Research is dedicated to fueling scientific progress with high-purity research materials. This stack represents the premier choice for investigating the science of tissue restoration.

Safety Data Sheet

Full GHS 16-section Safety Data Sheet for GLOW Blend, prepared per OSHA HazCom 2012 (29 CFR 1910.1200). Includes substance identity, handling & storage, PPE, stability, transport and regulatory information.

CAS No.

Not assigned

Formula

Not assigned

Mol. Weight

Per COA

Classification

Not hazardous (GHS)

Questions & answers

Glow Capsules frequently asked questions

High Quality · 99% Purity Guaranteed

Product Quality Guarantee

We are continuously conducting HPLC testing on all of our raw powders as well as our finished products to ensure the quality of what we ship. You can have the product you bought from us independently tested at any HPLC-licensed testing facility, and if the results come back negative, we will refund the following:

HPLC Test Fee

$100

Plus a full refund

Total order amount + shipping

For laboratory research use only. Not for human or animal consumption.

Glow Capsules1002mg / 1 Unit

$149.00

1